|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
1998-1-27
|
|
pubmed:abstractText |
To determine the toxicity and prognosis of patients with relapsed and refractory diffuse aggressive non-Hodgkin's lymphoma (NHL) who underwent an autologous bone marrow transplant (ABMT) using augmented preparative regimens, treated in a major cooperative group setting, and to examine prognostic factors for outcome.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
16
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
48-55
|
|
pubmed:dateRevised |
2007-11-14
|
|
pubmed:meshHeading |
pubmed-meshheading:9440722-Adult,
pubmed-meshheading:9440722-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:9440722-Bone Marrow Transplantation,
pubmed-meshheading:9440722-Carmustine,
pubmed-meshheading:9440722-Cause of Death,
pubmed-meshheading:9440722-Cyclophosphamide,
pubmed-meshheading:9440722-Disease-Free Survival,
pubmed-meshheading:9440722-Etoposide,
pubmed-meshheading:9440722-Female,
pubmed-meshheading:9440722-Humans,
pubmed-meshheading:9440722-Lymphoma, Non-Hodgkin,
pubmed-meshheading:9440722-Male,
pubmed-meshheading:9440722-Middle Aged,
pubmed-meshheading:9440722-Proportional Hazards Models,
pubmed-meshheading:9440722-Prospective Studies,
pubmed-meshheading:9440722-Recurrence,
pubmed-meshheading:9440722-Salvage Therapy,
pubmed-meshheading:9440722-Transplantation, Autologous,
pubmed-meshheading:9440722-Transplantation Conditioning,
pubmed-meshheading:9440722-Treatment Outcome
|
|
pubmed:year |
1998
|
|
pubmed:articleTitle |
Autologous bone marrow transplantation for patients with relapsed or refractory diffuse aggressive non-Hodgkin's lymphoma: value of augmented preparative regimens--a Southwest Oncology Group trial.
|
|
pubmed:affiliation |
Loyola University Stritch School of Medicine, Maywood, IL, USA.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, U.S. Gov't, P.H.S.,
Multicenter Study,
Clinical Trial, Phase II
|
